<DOC>
	<DOCNO>NCT00669747</DOCNO>
	<brief_summary>The primary objective study compare safety 100 mg carboplatin administer intraductally Day 1 twice Days 1 15 woman ductal carcinoma situ ( DCIS ) undergo surgical management 2 4 week follow Day 15 intraductal infusion . Secondary objective characterize biologic clinical effect respect : pharmacokinetics , extent disease MRI mammogram , histopathological assessment DCIS , biomarker measurement Ki-67 , TUNEL G-actin .</brief_summary>
	<brief_title>Study Of Intraductal Carboplatin In Women With Ductal Carcinoma In Situ ( DCIS )</brief_title>
	<detailed_description>This randomize , 3-arm , saline-controlled study involve woman undergo surgical management DCIS . Forty-five ( 45 ) woman diagnose DCIS core biopsy receive intraductal administration either carboplatin normal saline ( NS ) DCIS-involved breast duct . Thirty ( 30 ) patient ( i.e. , 15 patient per arm ) receive two intraductal infusion either 100 mg carboplatin NS Days 1 15 . Fifteen ( 15 ) patient receive intraductal infusion 100 mg carboplatin Day 1 intraductal infusion NS Day 15 . Patients undergo surgical resection 2 4 week follow Day 15 intraductal infusion ( i.e . 4 6 week diagnosis ) . The effect carboplatin DCIS pre-treatment core biopsy specimen resection specimen assess . Venous blood sample collect carboplatin PK analysis pre-dose 30 minute , 1 , 2 , 4 , 8 hour follow intraductal infusion Days 1 15 .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma Situ</mesh_term>
	<mesh_term>Carcinoma , Ductal</mesh_term>
	<mesh_term>Carcinoma , Intraductal , Noninfiltrating</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>Female 18 year age old Scheduled undergo surgical resection 2 week longer Pathological diagnosis DCIS require surgical resection DCIS diagnose core biopsy Mammogram within 6 week diagnosis Adequate organ function define follow criterion : Absolute neutrophil count ( ANC ) ≥ 1500/μl , Platelets ≥ 140,000/μl , Hemoglobin ≥ 12.0 g/dl , Creatinine &lt; 2.0 mg/dl Able sign inform consent Current diagnosis invasive inflammatory breast carcinoma DCIS microinvasion histology core needle biopsy Palpable mass Mass mammography Concurrent anticancer therapy Prior exposure carboplatin ( related current past diagnosis ) Prior radiation breast chest wall Prior areolar breast surgery interrupt communication ductal system nipple Presence breast implant Presence ulcerating fungal skin lesion infection breast Pregnant lactating Impaired cardiac function history cardiac problem Poor nutritional state ( determined clinician ) Presence serious infection Scheduled intraoperative radiation breast chest wall Allergies lidocaine marcaine Allergies image dye</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2008</verification_date>
	<keyword>Ductal Carcinoma In Situ</keyword>
	<keyword>DCIS</keyword>
	<keyword>Breast Cancer</keyword>
	<keyword>Carboplatin</keyword>
	<keyword>Intraductal</keyword>
</DOC>